HiFiBiO Therapeutics
Developing immunotherapies with DIS®
- B2B
- Has physical offices
- AI & machine learning
- Pharma & life sciences
- Multi-site
- International operations
- Has in-house R&D
- French-founded, headquartered abroad
- French-founded, headquartered in the US
About HiFiBiO Therapeutics
A multinational biotherapeutics company leveraging single-cell profiling technologies to develop antibody drugs for cancer and autoimmune disorders, fostering open-innovation partnerships
Key facts
- Industry
- Biotechnology
- Company size
- 11–50 employees
- Headquarters
- cambridge, massachusetts, United States
- Founded
- 2013
- Revenue
- $9.8M – $77.6MTamtam estimate
- Website
- hifibio.com
HiFiBiO Therapeutics at a glance
HiFiBiO Therapeutics is a B2B company in the Biotechnology industry, headquartered in cambridge, massachusetts, United States.
HiFiBiO Therapeutics was founded in 2013.
HiFiBiO Therapeutics has 11–50 employees.
HiFiBiO Therapeutics's revenue is $9.8M – $77.6M (Tamtam estimate).
Frequently asked questions about HiFiBiO Therapeutics
What is HiFiBiO Therapeutics's revenue?
Tamtam estimates HiFiBiO Therapeutics's annual revenue at $9.8M – $77.6M.
How many employees does HiFiBiO Therapeutics have?
HiFiBiO Therapeutics has 11–50 employees.
Where is HiFiBiO Therapeutics headquartered?
HiFiBiO Therapeutics is headquartered in cambridge, massachusetts, United States.
Selling to companies like HiFiBiO Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies